Does Wegovy build up in your system — and how long does that take?

Why the build-up happens: the half-life that makes weekly dosing work

Semaglutide's long half-life (roughly seven days) is not a side effect or a quirk. It is engineered into the molecule. When researchers designed the compound, they attached it to a fatty acid chain so it would bind to albumin (a protein in the blood), slowing the rate at which the body breaks it down. The result is a medicine that lingers long enough to need only one injection per week rather than daily dosing.

The practical consequence is accumulation. Each Wednesday's injection (or whichever day you choose) does not start from zero, there is still a meaningful amount of semaglutide from the previous week circulating in your system. Levels rise with each successive dose until, after roughly four to five weeks, the amount being cleared each week matches the amount being added. That balance point is called steady state, and it is where the medicine's appetite-suppressing effects are most consistent. Semaglutide's peak concentration within each week typically arrives one to three days after the injection.

The NHS medicines information for tirzepatide and semaglutide explains this pharmacokinetic principle in patient-friendly terms; for the precise figures, the NHS semaglutide page is the clearest starting point.

What accumulation means for dose increases and how you feel week to week

The fact that semaglutide builds up in your system is one reason the escalation schedule exists. Wegovy treatment starts at 0.25 mg, a dose chosen primarily for tolerability, not for its weight-management effect. Your prescriber then increases the dose in roughly four-weekly steps, moving through 0.5 mg, 1.0 mg, 1.7 mg and eventually 2.4 mg (or up to 7.2 mg with the higher-dose maintenance pen approved in the UK in early 2026).

Each step change triggers another accumulation cycle. After you move from 1.0 mg to 1.7 mg, for example, levels climb gradually over the following four to five weeks until a new steady state is reached. That is frequently when side effects such as nausea or reflux are most noticeable, not because anything has gone wrong, but because the concentration of semaglutide in your system is still rising. Understanding how semaglutide sustains its effect across the week can make the experience of those first weeks at a new dose feel less unpredictable.

It also explains why missing a single dose has a less dramatic effect than you might expect with a shorter-acting drug. The reservoir of semaglutide already in your system bridges the gap, though persistent missed doses will gradually reduce that buffer. Your prescriber or the patient information leaflet should always guide what to do if a dose is missed.

Does semaglutide build up in your system in a way that raises safety concerns?

The accumulation is factored into both the licenced dose schedule and the monitoring recommendations. It is not something that happens unexpectedly, the four-weekly step-up timeline is calibrated around the roughly five-week window it takes to reach steady state, so your prescriber has a clear picture of where your levels should be at each review point.

That said, if side effects are significant at a particular dose, the build-up means they may take a few weeks to fully settle, even if they started after a dose increase rather than immediately. The most common are gastrointestinal: nausea, loose stools, constipation, or reflux. These are usually mild to moderate and ease as steady state is maintained. Other questions about semaglutide's systemic effects come up regularly too, and are worth raising directly with your clinical team.

One area worth knowing about: pancreatitis is a recognised but infrequent serious side effect of GLP-1 medicines. The MHRA issued a Drug Safety Update on this in January 2026, highlighting that severe, persistent stomach pain (especially if it radiates to the back) warrants prompt medical attention. If that happens, seek help the same day rather than waiting for your next scheduled review.

For ongoing peace of mind about how the medicine behaves in your body over time, cost context for private treatment is one aspect patients often weigh up; our guide to Wegovy pricing in the UK covers what to look for and what all-in pricing actually means in practice.

When the build-up reverses: what happens when you stop Wegovy

Semaglutide clears gradually once you stop taking it. Given the approximately seven-day half-life, around half is gone after one week, half of the remainder after another week, and so on. Most people's systems are largely clear within four to five weeks of the final dose, though individual variation in metabolism, body composition and kidney function affects the precise timeline. More on what to expect as semaglutide clears is worth reading if you are considering stopping or taking a break.

The clinical relevance of that clearing period matters for a few specific situations. Women planning to conceive are advised to stop semaglutide and allow a wash-out before trying, in line with MHRA guidance, the exact recommended interval should be confirmed with your prescriber. Planned surgery is another context: tell your anaesthetist and surgical team that you have been taking a GLP-1 medicine, because gastric emptying may still be affected for several weeks after stopping. Keep a note of your last injection date so that information is to hand. Some patients keep a small card with it tucked next to the pen box in the fridge door, which is a simple habit worth starting from day one.

If you are trying to understand how quickly semaglutide leaves the body in more detail, that guide walks through the pharmacokinetics in plain terms. For anyone at the start of their treatment journey, our Wegovy overview covers the broader picture, and checking your eligibility with our prescribers is the natural first step if you are considering treatment.